<DOC>
	<DOCNO>NCT00597233</DOCNO>
	<brief_summary>This trial conduct South America . This aim trial evaluate comparative prandial blood glucose lower profile subject type 1 diabetes .</brief_summary>
	<brief_title>Human Insulin NPH Insulin Aspart Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Type 1 diabetes least 12 month Treatment insulin NPH Body Mass Index ( BMI ) 30 kg/m2 Total daily insulin dose great 1.40 IU/kg Treatment oral antidiabetic drug ( OADs )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>